| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10005943 | HBV | ENSG00000196139.14 | protein_coding | AKR1C3 | No | No | 8644 | A0A0A0MSS8 P42330 |
| TVIS10005944 | HBV | ENSG00000196139.14 | protein_coding | AKR1C3 | No | No | 8644 | A0A0A0MSS8 P42330 |
| TVIS10047432 | HBV | ENSG00000196139.14 | protein_coding | AKR1C3 | No | No | 8644 | A0A0A0MSS8 P42330 |
| TVIS30027111 | HIV | ENSG00000196139.14 | protein_coding | AKR1C3 | No | No | 8644 | A0A0A0MSS8 P42330 |
| TVIS30027112 | HIV | ENSG00000196139.14 | protein_coding | AKR1C3 | No | No | 8644 | A0A0A0MSS8 P42330 |
| TVIS30027113 | HIV | ENSG00000196139.14 | protein_coding | AKR1C3 | No | No | 8644 | A0A0A0MSS8 P42330 |
| TVIS30027114 | HIV | ENSG00000196139.14 | protein_coding | AKR1C3 | No | No | 8644 | A0A0A0MSS8 P42330 |
| TVIS30027115 | HIV | ENSG00000196139.14 | protein_coding | AKR1C3 | No | No | 8644 | A0A0A0MSS8 P42330 |
| TVIS30027116 | HIV | ENSG00000196139.14 | protein_coding | AKR1C3 | No | No | 8644 | A0A0A0MSS8 P42330 |
| TVIS30027117 | HIV | ENSG00000196139.14 | protein_coding | AKR1C3 | No | No | 8644 | A0A0A0MSS8 P42330 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | AKR1C3 |
|---|---|
| DrugBank ID | DB02056 |
| Drug Name | Prostaglandin D2 |
| Target ID | BE0000592 |
| UniProt ID | P42330 |
| Regulation Type | |
| PubMed IDs | 17139284; 17016423; 10592235 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
| Groups | Investigational |
| Direct Classification | Prostaglandins and related compounds |
| SMILES | [H][C@](O)(CCCCC)C=C[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])CC=C/CCCC(O)=O |
| Pathways | Arachidonic Acid Metabolism; Flurbiprofen Action Pathway; Rofecoxib Action Pathway; Bromfenac Action Pathway; Ketoprofen Action Pathway; Sulindac Action Pathway; Fenoprofen Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; Tolmetin Action Pathway; Lornoxicam Action Pathway; Trisalicylate-Choline Action Pathway; Antrafenine Action Pathway; Celecoxib Action Pathway; Suprofen Action Pathway; Indomethacin Action Pathway; Valdecoxib Action Pathway; Ketorolac Action Pathway; Acetylsalicylic Acid Action Pathway; Antipyrine Action Pathway; Tiaprofenic Acid Action Pathway; Ibuprofen Action Pathway; Tenoxicam Action Pathway; Salicylic Acid Action Pathway; Diclofenac Action Pathway; Nepafenac Action Pathway; Leukotriene C4 Synthesis Deficiency; Magnesium Salicylate Action Pathway; Diflunisal Action Pathway; Etodolac Action Pathway |
| PharmGKB | |
| ChEMBL | CHEMBL1235252 |
